Перейти к основному содержанию
AkademIndex

Продукты

Для разработчиков

AkademBaseОткрытый API экосистемы
Обзорная статья

The miR-200 Family of microRNAs: Fine Tuners of Epithelial-Mesenchymal Transition and Circulating Cancer Biomarkers

Ilaria CavallariVeneto Institute of Oncology IOV–IRCCS, 35128 Padova, ItalyFrancesco CiccareseVeneto Institute of Oncology IOV–IRCCS, 35128 Padova, ItalyEvgeniya SharovaVeneto Institute of Oncology IOV–IRCCS, 35128 Padova, ItalyLoredana UrsoDepartment of Surgery, Oncology and Gastroenterology, University of Padua, 35128 Padova, ItalyVittoria RaimondiVeneto Institute of Oncology IOV–IRCCS, 35128 Padova, ItalyMicol Silic‐BenussiVeneto Institute of Oncology IOV–IRCCS, 35128 Padova, ItalyDonna M. D’AgostinoDepartment of Biomedical Sciences, University of Padua, 35131 Padova, ItalyVincenzo CiminaleDepartment of Surgery, Oncology and Gastroenterology, University of Padua, 35128 Padova, Italy
2021en
ABI

Аннотация

The miR-200 family of microRNAs (miRNAs) includes miR-200a, miR-200b, miR-200c, miR-141 and miR-429, five evolutionarily conserved miRNAs that are encoded in two clusters of hairpin precursors located on human chromosome 1 (miR-200b, miR-200a and miR-429) and chromosome 12 (miR-200c and miR-141). The mature -3p products of the precursors are abundantly expressed in epithelial cells, where they contribute to maintaining the epithelial phenotype by repressing expression of factors that favor the process of epithelial-to-mesenchymal transition (EMT), a key hallmark of oncogenic transformation. Extensive studies of the expression and interactions of these miRNAs with cell signaling pathways indicate that they can exert both tumor suppressor- and pro-metastatic functions, and may serve as biomarkers of epithelial cancers. This review provides a summary of the role of miR-200 family members in EMT, factors that regulate their expression, and important targets for miR-200-mediated repression that are involved in EMT. The second part of the review discusses the potential utility of circulating miR-200 family members as diagnostic/prognostic biomarkers for breast, colorectal, lung, ovarian, prostate and bladder cancers.

Перевод пока недоступен

Идентификаторы

Цитирования и источники

Цитирований: 2Использованных источников: 0